Continuous Botox® use safe and effective says international study

An international study released at the American Society for Dermatologic Surgery meeting in San Diego has shown that repeated Botox® treatments to treat facial wrinkles over many years are safe.

The retrospective review entitled “Evolution of Facial Aesthetic Treatment over Five or More Years: An International Retrospective, Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment” was conducted by Alastair Carruthers, FRCPC and concluded that the injectable wrinkle-relaxer, manufactured by Allergan, can be used safely in conjunction with other aesthetic treatments and that longterm patients are satisfied with their results.

Carruthers and his co-authors reviewed the charts of and interviewed nearly 200 patients treated with Botox® for five or more continuous years during the time period of 1999 to 2012. Patients received at least one treatment each year for glabellar frown lines. The patients had 5,112 total treatment sessions, averaging two or more treatments each year over an average of nine years. Some patients received treatments for as long as 16 years.

Researchers reviewed the records for the facial areas treated, number of treatments, dosage for each facial area, whether the patient had other facial aesthetic treatments and any Botox®-related adverse events. Patients were an average age of 46.3 years at the time of the first treatment. The researchers also interviewed all patients to get their personal assessments of the treatments and found that the longer patients were treated, the younger they perceived themselves to look.

An international study released at the American Society for Dermatologic Surgery meeting in San Diego has shown that repeated Botox® treatments to treat facial wrinkles over many years are safe.

The retrospective review entitled “Evolution of Facial Aesthetic Treatment over Five or More Years: An International Retrospective, Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment” was conducted by Alastair Carruthers, FRCPC and concluded that the injectable wrinkle-relaxer, manufactured by Allergan, can be used safely in conjunction with other aesthetic treatments and that longterm patients are satisfied with their results.

Carruthers and his co-authors reviewed the charts of and interviewed nearly 200 patients treated with Botox® for five or more continuous years during the time period of 1999 to 2012. Patients received at least one treatment each year for glabellar frown lines. The patients had 5,112 total treatment sessions, averaging two or more treatments each year over an average of nine years. Some patients received treatments for as long as 16 years.

Researchers reviewed the records for the facial areas treated, number of treatments, dosage for each facial area, whether the patient had other facial aesthetic treatments and any Botox®-related adverse events. Patients were an average age of 46.3 years at the time of the first treatment. The researchers also interviewed all patients to get their personal assessments of the treatments and found that the longer patients were treated, the younger they perceived themselves to look.